Cediprof Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CEDIPROF INC, and what generic and branded alternatives to CEDIPROF INC drugs are available?
CEDIPROF INC has three approved drugs.
Summary for Cediprof Inc
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Cediprof Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-009 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-007 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-003 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-011 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Cediprof Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 208737-001 | Feb 1, 2019 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-012 | Dec 8, 2003 | AB1,AB2,AB3 | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cediprof Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-009 | Mar 1, 2002 | 6,399,101 | See Plans and Pricing |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-003 | Mar 1, 2002 | 6,399,101 | See Plans and Pricing |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-008 | Mar 1, 2002 | 6,399,101 | See Plans and Pricing |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-001 | Mar 1, 2002 | 6,399,101 | See Plans and Pricing |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-006 | Mar 1, 2002 | 6,399,101 | See Plans and Pricing |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-004 | Mar 1, 2002 | 6,399,101 | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
